Sachin Shrikant Parikh, MD
Facial Plastic Surgery · Cupertino
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 6 carriers
- Office
- 1
Offices
1 location
Plans that list them
25 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Parikh’s office at (650) 396-7111 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A96960 · Current
Licensed to practise in California · since 2006 · expires 2027-12-31 · Florida State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Alma at Addison Surgery Center, LLCAmbulatory Surgery Center · Palo Alto, CA50% owner since 2022 · accredited by AAAASFAccreditation Renewed1 inspection, 1 with deficiencies · last 2025-08-13
Drugs they prescribed that Part D paid
$3,111
Pharmacies billed $3,111 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (30 of 237) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
226 generic and 11 brand-name prescriptions · $3,111 in drug cost · 67 antibiotic prescriptions to 40 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Valacyclovir | 29 | $348 | $12 |
| Cephalexin | 26 | $330 | $13 |
| Scopolamine | 21 | $268 | $13 |
| Ondansetron Odt | 25 | $204 | $8 |
| Hydrocodone-Acetaminophen | 22 | $159 | $7 |
See all 8 drugs
| Valacyclovir | 29 | $348 | $12 |
| Cephalexin | 26 | $330 | $13 |
| Scopolamine | 21 | $268 | $13 |
| Ondansetron Odt | 25 | $204 | $8 |
| Hydrocodone-Acetaminophen | 22 | $159 | $7 |
| Ciprofloxacin | 20 | $120 | $6 |
| Lorazepam | 15 | $48 | $3 |
| Sulfamethoxazole-Trimethoprim | 13 | $36 | $3 |
Year by year
| 2024 | 237 | 51 | 13% (30) | 5% | $3,111 |
| 2023 | 206 | 38 | 18% (36) | None | $2,798 |
| 2022 | 136 | 27 | 15% (21) | None | $1,550 |
| 2021 | 153 | 29 | 20% (30) | None | $2,226 |
| 2020 | 67 | 18 | 18% (12) | None | $947 |
| 2019 | 128 | 20 | None | None | $3,350 |
| 2018 | 106 | 17 | None | 11% | $3,277 |
| 2017 | 70 | 19 | None | None | $2,652 |
| 2016 | 118 | 31 | 18% (21) | None | $3,099 |
| 2015 | 108 | 23 | 18% (19) | None | $5,182 |
| 2014 | 197 | 44 | 19% (37) | 17% | $15,599 |
| 2013 | 278 | 98 | 26% (73) | 18% | $9,565 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Cephalexin | 31 | $279 | $9 |
| Scopolamine | 19 | $217 | $11 |
| Oxycodone-Acetaminophen | 18 | $194 | $11 |
| Ondansetron Odt | 23 | $158 | $7 |
| Hydrocodone-Acetaminophen | 18 | $150 | $8 |
| Sulfamethoxazole-Trimethoprim | 11 | $70 | $6 |
| Lorazepam | 20 | $41 | $2 |
2022: 5 drugs
| Cephalexin | 21 | $216 | $10 |
| Scopolamine | 13 | $171 | $13 |
| Hydrocodone-Acetaminophen | 18 | $158 | $9 |
| Ondansetron Odt | 14 | $133 | $9 |
| Lorazepam | 13 | $29 | $2 |
2021: 4 drugs
| Cephalexin | 27 | $220 | $8 |
| Hydrocodone-Acetaminophen | 28 | $186 | $7 |
| Valacyclovir | 13 | $160 | $12 |
| Lorazepam | 17 | $41 | $2 |
2020: 1 drug
| Cephalexin | 13 | $79 | $6 |
2019: 3 drugs
| Hydroxychloroquine Sulfate | 26 | $1,732 | $67 |
| Gabapentin | 13 | $137 | $11 |
| Sertraline | 20 | $68 | $3 |
2018: 2 drugs
| Hydroxychloroquine Sulfate | 13 | $851 | $65 |
| Sertraline | 13 | $43 | $3 |
2016: 3 drugs
| Hydroxychloroquine Sulfate | 13 | $1,488 | $114 |
| Cephalexin | 18 | $93 | $5 |
| Oxycodone-Acetaminophen | 11 | $74 | $7 |
2015: 3 drugs
| Hydroxychloroquine Sulfate | 20 | $2,878 | $144 |
| Hydrocodone-Acetaminophen | 16 | $293 | $18 |
| Cephalexin | 11 | $57 | $5 |
2014: 5 drugs
| Methotrexate | 31 | $1,789 | $58 |
| Hydroxychloroquine Sulfate | 20 | $785 | $39 |
| Leflunomide | 13 | $523 | $40 |
| Hydrocodone-Acetaminophen | 36 | $420 | $12 |
| Cephalexin | 28 | $178 | $6 |
2013: 5 drugs
| Methotrexate | 27 | $1,142 | $42 |
| Leflunomide | 12 | $731 | $61 |
| Hydrocodone-Acetaminophen | 66 | $621 | $9 |
| Cephalexin | 52 | $483 | $9 |
| Hydroxychloroquine Sulfate | 21 | $369 | $18 |
Money from drug and device companies
$357 in 2025
| 2025 | 2 | 12 | None | $357 |
| 2024 | 2 | 31 | $13,461 | $14,900 |
| 2023 | 2 | 20 | $3,466 | $4,400 |
| 2022 | 1 | 13 | None | $315 |
| 2021 | 2 | 20 | None | $351 |
| 2020 | 1 | 10 | None | $228 |
| 2019 | 2 | 13 | $2,200 | $2,785 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $333 | 11 payments
|
| Revance Therapeutics | None | $24 | 1 payment
|
See all 12 published payments
| Revance Therapeutics | Meals · 2025-12-08 | None | $24 |
| Abbvie | Meals · 2025-11-14 | Botox | $15 |
| Abbvie | Meals · 2025-09-16 | None | $27 |
| Abbvie | Meals · 2025-06-05 | Botox | $17 |
| Abbvie | Meals · 2025-05-15 | None | $25 |
| Abbvie | Meals · 2025-05-01 | None | $20 |
| Abbvie | Meals · 2025-04-25 | Botox | $128 |
| Abbvie | Meals · 2025-04-23 | Botox | $20 |
| Abbvie | Education · 2025-03-21 | Botox | $10 |
| Abbvie | Meals · 2025-02-13 | Botox | $33 |
| Abbvie | Meals · 2025-02-12 | Botox | $28 |
| Abbvie | Meals · 2025-02-09 | None | $10 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $14,900
| Abbvie | Botox | $14,641 | 26 payments
|
| Galderma Laboratories L.P. | Dysport | $259 | 5 payments
|
2023: $4,400
| Abbvie | Botox | $4,246 | 18 payments
|
| Galderma Laboratories L.P. | None | $153 | 2 payments
|
2022: $315
| Allergan | Botox | $315 | 13 payments
|
2021: $351
| Allergan | Botox | $296 | 17 payments
|
| Galderma Laboratories L.P. | None | $55 | 3 payments
|
2020: $228
| Allergan | Botox Cosmetic | $228 | 10 payments
|
2019: $2,785
| Allergan | Botox Cosmetic | $2,770 | 12 payments
|
| Galderma Laboratories L.P. | None | $15 | 1 payment
|
Professional record
- NPI
- 1669670592
- Licence
- CA A96960, NY 256203-1California A96960: Current · expires 2027-12-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207YS0123X (207YS0123X); Federal specialty code 2082S0099X (2082S0099X)
- Mailing address
- 10385 Calvert Dr, Cupertino, CA, 95014
- NPI first listed
- 2007-07-03
- NPI last updated
- 2011-10-21
This is when the NPI record was last certified, not a medical board exam.